Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-07-12FDA Approved: GILOTRIF — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved Gilotrif (afatinib) from Boehringer Ingelheim for patients with metastatic non-small cell lung cancer whose tumors have activat…
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC [Phase 2]
This Phase 2 clinical trial evaluating carboplatin plus gemcitabine followed by concomitant chemoradiation for non-resectable stage III non-…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Temsirolimus and Radiation for Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating temsirolimus in combination with radiation therapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2013-07-11Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating combination chemotherapy for stage IIIB, stage IV, or recurrent non-small cell lung cancer has been withdrawn fro…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 study of DX-8951f in previously untreated stage IIIB or stage IV non-small cell lung cancer has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update evaluating the combination of chemotherapy, amifostine, and radiation therapy in patients with non-small cel…
-
CLINICAL_TRIALS research · 2013-07-08Clinical Trial Update: A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers [NA]
This document provides a clinical trial update on sequential pemetrexed maintenance therapy for non-small cell lung cancer and discusses rel…
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC [Phase 2]
A Phase II trial of docetaxel and carboplatin with radiotherapy and surgical resection for stage III non-small cell lung cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing surgery with and without chemotherapy in patients with Stage I non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2013-07-03Clinical Trial Update: VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer
Clinical trial update suggests VEGF receptor status may predict benefit from bevacizumab in advanced non-small cell lung cancer, including p…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial of veliparib with cisplatin and gemcitabine in advanced biliary tract, pancreatic, urothelial, and non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) [Phase 3]
A Phase 3 clinical trial evaluated whether adding enoxaparin (LMWH) to first-line chemotherapy improves survival and symptom control in pati…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated a combination of docetaxel, cisplatin, pegfilgrastim, and erlotinib in patients with stage IIIB or stage IV non-sm…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 first-line trial of tamibarotene in combination for advanced non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS other · 2013-06-28Clinical Trial Update: To Evaluate the Impact of PET/CT on Radiation Treatment Planning in Relation to Changes in GTV in Stage 3 NSCLC
This document notes that the clinical trial evaluating the impact of PET/CT on radiation treatment planning for stage III non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating combination chemotherapy as induction therapy for stage III non-small cell lung cancer has completed.
-
FDA label_change · 2013-06-26FDA Approved: DOCETAXEL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for docetaxel, resulting in changes to the product labeling. The changes may include updates to indi…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This document reports results from a Phase 2 trial of TLK286 in patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating induction Erlotinib in stage IIIA (N2) non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating the addition of tirapazamine to standard chemotherapy for stage IIIB/IV non-small cell lung cancer has been compl…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer [Phase 2]
Phase 2 clinical trial update examining the combination of phenylbutyrate and azacitidine in patients with acute myeloid leukemia, myelodysp…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab in combination with chemotherapy for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating a vaccine therapy in patients with stage III non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Phase I Study of Vorinostat and Sorafenib in Advanced Cancer [Phase 1]
Phase I study update of the combination of vorinostat and sorafenib in patients with advanced cancer, with completed status. Diseases includ…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery [NA]
This clinical trial update reports the completion of a study evaluating vaccine therapy combined with chemotherapy and radiation therapy for…